Disparities in medical oncology visit adherence among African American (AA) men with prostate cancer (pCa).

Authors

null

Ariel Ann Nelson

The Medical College of Wisconsin, Department of Medicine, Division of Hematology and Oncology, Milwaukee, WI

Ariel Ann Nelson , Christina Ladwig , Kristin Riemersma , Kathryn A. Bylow , Deepak Kilari

Organizations

The Medical College of Wisconsin, Department of Medicine, Division of Hematology and Oncology, Milwaukee, WI, Froedtert Hospital & The Medical College of Wisconsin, Milwaukee, WI

Research Funding

No funding received
None.

Background: AA patients (pts) with pCa tend to have worse outcomes when compared to Caucasians. Disparities in access to healthcare among AA pts with pCa is a significant barrier to improvement in outcomes. Medical oncology visit attendance among this population has not been thoroughly investigated. Methods: Pts with a diagnosis (dx) of pCa scheduled to see a provider (MD or advanced practice provider) at a single academic institution medical oncology clinic between January 2022 and December 2022 were retrospectively identified. Pts were categorized by self-identified race. The total number of scheduled clinic visits was recorded, and each visit was categorized by visit status; completed, cancelled, no-show, or left clinic. The reason for visit cancellation was assessed and cancelled visits for non-pt driven reasons (ie. scheduling error) were removed. The data were summarized using descriptive statistics. Z-test and Chi-square analysis were utilized to compare proportions of visits between AA and Caucasian pts and the association of race with visit status. Results: A total of 992 pts were selected, 80% (n = 792) were Caucasian and 16% (n = 162) were AA, representing 4231 clinic visits during the study period. AA pts accounted 18% (n = 763) of the total scheduled visits. 94% of visits (n = 3962) were follow up and 6% (n = 269) were new pt visits. 86% of all scheduled visits were completed and 10 % (n = 436) were cancelled for pt driven reasons. Roughly 3% (n = 135) of visits were no-show. AA pts had fewer completed visits compared to Caucasian pts, 78% vs 88% (p < 0.001) and a higher no-show rate of 10% vs 1.5% (p < 0.001). The cancellation rate was similar between AA and Caucasian pts, 11% vs 10% (p = 0.33). The combined no-show and cancellation rate for AA pts was 22% vs 12% for Caucasian pts (p < 0.001). There was a significant association between AA race and no-show visit status (p < 0.001). Conclusions: AA men with pCa have much poorer visit adherence to scheduled medical oncology visits compared to their Caucasian counterparts. Identifying reasons for no-show and visit cancellations and targeted interventions to improve access to care are needed to improve outcomes.

Clinic visit status by race.

RaceTotal ScheduledCompletedNo-showCancellationLeft Clinic
White32792896493313
AA76359580880
Asian6660060
American Indian / Native Alaskan2218130
Hawaiian/Pacific Islander20110
Other8372470
Declined to Answer1616000
Total423136571354363

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Access to Care

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr e18671)

DOI

10.1200/JCO.2023.41.16_suppl.e18671

Abstract #

e18671

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Annual Meeting

Clinician documentation of shared decision making for prostate cancer screening.

First Author: Phuong Nhi Le

First Author: Daniel Sabater Minarim

Abstract

2022 ASCO Quality Care Symposium

Racial/ethnic disparities in patient care experiences among prostate cancer survivors: A SEER-CAHPS study.

First Author: Ambrish Pandit

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Assessing disparities in pancreatic cancer outcomes in African Americans.

First Author: Shiva Shrotriya